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Abstract DING proteins have a characteristic DINGGG- or
closely related N-terminal sequence. One is found in human
synovial £uid, and may be associated with rheumatoid arthritis.
Other examples have receptor or signalling roles in various
human and animal cells, or are involved in biomineralisation,
and several of them bind to phytochemicals. As plant DING
proteins have recently been discovered, we hypothesise that
the DING protein-phytochemical association may represent
one aspect of a ubiquitous receptor-linked signalling system.
Several microbial proteins related to DING proteins have phos-
phatase activity, which may relate to biomineralisation in
eukaryotic systems. Plant DING proteins and their microbial
relatives may elicit allergic responses leading to arthritic
disease. % 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The name ‘DING protein’ seems to have emerged by con-
sensus for ubiquitous but genetically elusive proteins, usually
with a molecular weight of around 40 kDa, of which the
N-terminal sequence is DINGGG- [1]. It was ¢rst reported as
a fragment of a larger protein, found in rheumatoid arthritis
(RA) synovial £uid and secreted by RA synovial ¢broblasts.
Closely related proteins have been reported as having receptor
or signalling roles in various human and animal cells, and as
components of urinary stones and gallstones. Recently, it was
discovered that DING proteins are not restricted to the ani-
mal kingdom, since proteins with almost identical N-termini
have been puri¢ed from several higher plant species. In addi-
tion, a variety of prokaryotic proteins all related to phosphate
transport or metabolism have N-terminal sequences strongly
resembling the typical eukaryotic DING protein N-terminus.
2. DING proteins in RA
The synovial £uid of RA patients contains a T-cell activat-
ing factor, which acts in concert with interleukin 2 [2,3]. The
factor has been puri¢ed from RA synovial £uid and from the
conditioned medium of cultured RA synovial ¢broblasts. This
synovial stimulatory protein (SSP) acts as an autoantigen, to
which T-lymphocytes from RA patients respond [3^5].
In SDS^PAGE, the SSP runs as a 205 kDa protein, which
appears to consist of subunits of about 70 kDa (under reduc-
ing conditions), and of about 60 kDa (under non-reducing
conditions), which suggests the presence of an internal disul-
¢de bridge. Partial tryptic digestion of the 70 kDa protein
yielded fragments of 40, 27 and 25 kDa which had a common
N-terminal sequence of DINGGG-. The partial digestion also
resulted, in addition to these polypeptides, in an 11-amino
acid peptide with 100% homology to human IgG [4]. In
RA, rheumatoid factors are immunologically directed to
IgM and IgG leading to a so-called seropositive RA. It is
thus possible that traces of SSP-antibody immune complexes
may be responsible for the observed lymphocyte activation
[6^8].
Independent research on growth regulation by the leech
anticoagulant, hirudin, identi¢ed a protein known initially
as the hirudin-sensitive ¢broblast proteinase (HSFP). It was
isolated from human skin ¢broblast cytoplasmic extracts, and
from ¢broblast-conditioned culture medium, with hirudin-
agarose a⁄nity columns. This protein had a molecular weight
of about 38^40 kDa under non-reducing conditions, and an
N-terminal amino acid sequence identical to the large SSP
fragments [9]. Subsequent work has indicated that the proteo-
lytic activity associated with early HSFP isolates was absent
from later preparations, and may have represented a trace
contaminant [1].
Internal peptide sequences predicted from the sequence of a
cDNA for the 40 kDa HSFP (see below) have been used to
generate two antisera, both of which cross-react with the 40
and 200 kDa proteins from ¢broblasts and with the 200 kDa
protein from synovial £uid. The 200 kDa protein thus seems
to correspond to the SSP, and has several sequences and epi-
topes in common with the 40 kDa protein, now known as the
DING protein [1].
DING-speci¢c antisera have been used to show that most
human synovial £uid samples, including normal and arthritis
samples, do not contain the 40 kDa protein, but do possess
the cross-reacting 200 kDa protein. Both the 40 and 200 kDa
proteins are secreted by normal, osteoarthritis and RA syno-
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vial ¢broblasts, but only the 40 kDa DING protein is found
in synovial cell cytoplasm [1]. This distribution pattern is con-
sistent with synthesis and secretion of the SSP from synovial
cells, followed by proteolytic processing and re-internalisation
of the resulting DING protein.
These proteins have an autocrine growth-promoting func-
tion which does not seem to involve interactions with other
soluble, secreted proteins, since a⁄nity chromatography of
SSP/DING did not result in the co-puri¢cation of other pro-
teins. It seems most likely that there is a membrane- or extra-
cellular matrix-bound receptor for the DING protein. Inter-
nalisation into the cytoplasmic compartment after interaction
with this receptor would account for the existence of the
40 kDa cytoplasmic protein.
Though it is clear that SSP/DING is not unique to RA, it
may be involved in the aetiology of RA through the stimula-
tion of T-cells. In addition, stimulation of ¢broblast prolifer-
ation by SSP/DING may contribute to the synovial hyper-
plasia, joint swelling and the formation of the destructive
pannus, which are seen in RA [10,11]. We have shown that
hirudin, which binds ¢broblast DING protein (see below), as
well as antibodies directed against internal DING peptides,
can inhibit this proliferation [1,9].
3. Other animal DING proteins
A 39 kDa protein with a DINGGG- N-terminus has been
isolated as a genistein-binding protein from human breast
carcinoma cell-conditioned medium (M. Belenky, H. Kim
and S. Barnes, personal communication). Genistein, a soy-
bean-derived iso£avone, is well known as an oestrogen ana-
logue and tyrosine kinase inhibitor, but the kinetics of the
growth-inhibitory e¡ect of genistein on breast carcinoma cells
indicate that these activities are not signi¢cant [12]. One sug-
gestion is that genistein may interact with transforming
growth factor L signalling pathways [13]. Genistein is also
known to inhibit DNA replication and cell cycle progression,
and to promote apoptosis in some cell types, so it has pleio-
tropic e¡ects upon cell proliferation [14^16]. It seems possible
that at least some of these e¡ects may stem from the inter-
action of genistein with a secreted, autocrine stimulatory pro-
tein identical or related to the DING protein.
A 40 kDa protein, isolated from rat neurones, functions as
a membrane-associated receptor for the principal nicotine me-
tabolite, cotinine, and may be responsible for the non-cholin-
ergic activities of nicotine [17]. The N-terminal sequence
shows greater than 80% identity with the human DING se-
quence. This ¢nding indicates that DING proteins have a
broader scope as signalling molecules in mammalian cells.
Taken together with the ¢ndings on genistein, it suggests
that a number of phytochemicals may have the ability to
interact with DING proteins, and thus to in£uence signalling
to animal cells.
A 40 kDa turkey air sac £uid protein with a high degree of
homology (ca 85% identity) to SSP/DING has also been re-
ported. This protein, named LFPBP-40 (lipid-free polysaccha-
ride-binding protein), exists as a multimer of six covalently
bound subunits. It is involved in bacterial adhesion to epithe-
lial cells in respiratory infections by its ability to bind micro-
bial surface polysaccharides through a lectin-like activity [18].
Other examples of DING proteins in animals are known,
and reinforce the view that this is a family of proteins with
structural similarities but divergent functions. A short N-ter-
minal sequence of a 40 kDa protein, extracted from human
urine and gallstones, has 60% identity with the synovial £uid
and ¢broblast DING protein sequences [19]. A 39 kDa sialo-
protein called the crystal adhesion inhibitor is secreted by
monkey renal epithelial cells, and was isolated by binding to
calcium oxalate crystals [20]. It may act to prevent epithelial
attachment of such crystals and to block kidney stone nucle-
ation. Its sialic acid component is essential to this activity, but
the polypeptide is highly homologous (s 90% identity) with
the SSP/DING N-terminus. Thus DING proteins act to pre-
vent nucleation of kidney stones, but are also incorporated
into such stones when they do form. These phenomena are
not irreconcilable. All that can be stated with certainty at this
stage is that DING proteins are implicated in the calci¢cation
of stones.
4. DING proteins in plants
Until very recently, DING proteins or DNA coding sequen-
ces had never been described in plants. However, the ¢rst
plant DING protein was recently identi¢ed in a search for
proteins interacting with germin-like proteins (GLPs; A. Ber-
na and F. Bernier, unpublished observations). This yielded a
tobacco extracellular 40 kDa protein, the N-terminal sequence
of which has about 90% identity with the N-termini of animal
DING proteins. Similar proteins have now been detected in
tomato, potato, sweet potato, wheat and in Arabidopsis thali-
ana. Plant DING proteins can be found in various tissues as
well as in culture medium of in vitro propagated cells (A.
Berna and F. Bernier; T. Perera and K. Scott; unpublished
observations).
GLPs are ubiquitous plant extracellular glycoproteins en-
coded by diverse gene families. Despite their name, they are
not restricted to germination. In fact, GLP genes display a
wide array of regulated expression patterns resulting in the
presence of GLPs in all plant tissues at all developmental
stages and also in response to stress conditions. The functions
of several GLPs have been identi¢ed: some are enzymes (ox-
alate oxidase, superoxide dismutase, nucleotide-sugar pyro-
phosphatase/phosphodiesterase; [21]), some play a structural
role in reinforcing the wall to resist pathogenic attack, where-
as others act as cell-surface receptors for molecules like auxin
or Rhizobium rhicadhesin. However, the precise function of
most of these proteins remains unknown. Based on current
knowledge of GLPs, it is hypothesised that they might repre-
sent a family of cell-surface proteins involved in signalling
between the extra- and intra-cellular spaces [22].
The potato and A. thaliana 40 kDa DING proteins cross-
reacted strongly with an antiserum to the ¢broblast DING
N-terminus and weakly with antisera against ¢broblast inter-
nal epitopes. This indicates that the plant-mammalian homol-
ogy is not merely in the N-terminal domains, and argues for a
correspondingly high degree of functional conservation in
some DING proteins. However, neither A. thaliana nor sweet
potato DING proteins bound to hirudin-agarose columns,
and there are also di¡erences in the molecular weights of
putative plant DING protein precursors, detected during iso-
lation (T. Perera and K. Scott; unpublished observations). As
in animals, there thus seem to be structurally divergent DING
proteins in plants, which may also re£ect functional di¡eren-
ces.
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5. Microbial relatives of DING proteins
Preliminary data suggest that the DINGGG sequence may
be present in Candida albicans, demonstrating that this pro-
tein family may be highly ubiquitous in eukaryotes (R. Wu«rz-
ner, personal communication). It is also found in prokaryotic
organisms, as a search of the databases revealed that a group
of microbial proteins shares a signi¢cant homology with the
¢rst 14 amino acids of eukaryotic DING proteins. With one
uncategorised exception, all these proteins are periplasmic al-
kaline phosphatases or periplasmic phosphate-binding pro-
teins that display a low overall amino acid identity (Fig. 1).
6. Exogenous DING proteins and RA
Having expanded the DING protein story to include plant
and microbial examples, it is worthwhile revisiting the causa-
tion of RA. Rheumatic disease has long been thought to rep-
resent an interaction of environmental agents on a back-
ground of genetic susceptibility. RA may be triggered by
infections or by an allergic response. Herpesviruses (EBV;
HHV-6, HHV-8), retroviruses and parvoviruses are consid-
ered possible aetiological agents in autoimmune diseases
such as RA, with a particular emphasis on Sjogren’s syn-
drome [23^25]. The link between SSP/DING and arthritis is
strengthened by another recent study, which showed that the
DING protein co-puri¢ed with a hepatitis virus from infected
animals [26]. The signi¢cance of this ¢nding is unclear, but it
is consistent with the observation that hepatitis patients often
develop arthritic lesions, and suggests that proteolytic process-
ing of SSP to DING may occur during this process. It is
possible that an immune response to a DING protein, initially
presented as a bacterial antigen, or complexed with a virus,
could lead to subsequent autoimmune reactions in the devel-
opment of RA. In addition, DING proteins, being very stable
and widely distributed in plants, could act as allergens. Inter-
estingly, germins and GLPs are now being recognised as po-
tential food allergens [27,28]. The immunologically functional
areas in the gut, known as Peyer’s patches, might be respon-
sible for an immune response to an exogenous DING protein,
which could then result in autoimmune e¡ects involving en-
dogenous DING protein in the synovial £uid.
The ¢rst reports of plant DING proteins were in New
World plants, such as tomato, potato, sweet potato and to-
bacco. This initially seemed to support the controversial hy-
pothesis that RA originated in the New World, arising in
Europe as a consequence of allergic responses to newly intro-
duced food plants [29]. Temporal and geographical variability
in the epidemiology of RA is indicated by palaeopathological
evidence that RA was common in the New World from 4000
B.C., but was much more rare in Europe before the 17th
century and unknown in Africa before the 20th century. How-
ever, more recent work has shown that a DING protein is
also present in wheat, a traditional European food crop (A.
Berna and F. Bernier, unpublished observations). Antibodies
to unspeci¢ed wheat proteins are common in RA patients,
though elevated immune responses to other dietary proteins
were also noted [30]. More detailed analysis of DING protein
distribution in the plant kingdom and in various parts of
edible plants will be necessary to clarify this issue.
Another possibility, consistent with the ‘New World origin’
hypothesis, is that inoculation by tobacco smoke in the lungs
might lead to RA. Many studies support the concept that
cigarette smoking increases the likelihood of the onset of
RA (reviewed in [31]). When compared to individuals who
have never smoked, signi¢cant increases in RA seropositivity
have been reported in current smokers and in ex-smokers [32].
Like the gut, the lung is also characterised by immunologi-
cally functional sites which could respond to tobacco DING
protein as an antigen. Possible interactions between cotinine
and endogenous DING proteins may also be involved in the
increased initiation of RA in smokers. Cotinine and nicotine
are known to have e¡ects on cell proliferation, both positive
and negative, on vascular smooth muscle cells and periodontal
ligament ¢broblasts, respectively [33,34]. No evidence is yet
available concerning synovial cells, but it seems possible that
nicotine and its metabolite may also in£uence their prolifer-
ation.
7. DING proteins and biomineralisation
The involvement of DING proteins in the formation of
gallstones and kidney stones has already been discussed, as
has the fact that many of the microbial homologues act as
Fig. 1. Alignment of the N-terminal sequences of animal and plant DING proteins (top) and of the microbial relatives of these (bottom). Ani-
mal and plant sequences were all derived from N-terminus protein sequencing. Microbial sequences were deduced from DNA sequences and
are located at or very near the predicted N-terminus of the mature protein. Protein molecular weights were either determined by gel electropho-
resis (eukaryotic proteins) or predicted from the sequence (prokaryotic proteins). Amino acid residues conserved in at least 85% of the eukary-
otic proteins are shown in pale grey, whereas changes considered as conservative are shown in lower case text. pPBP: periplasmic phosphate-
binding protein.
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phosphatases. The microbial DING proteins may have func-
tional as well as structural similarities with some of the animal
proteins, since generation (by hydrolysis of organic phos-
phates) and immobilisation of large quantities of free phos-
phate is an essential part of calci¢cation in animal systems. It
is known that this process occurs in arthritic synovial £uid,
where nucleoside triphosphate pyrophosphatase is thought to
be the key enzyme [35,36]. It may also be signi¢cant that
gallstones and kidney stones are more prevalent in RA pa-
tients [37,38]. Potential interactions of all DING proteins with
calcium and phosphate ions should be systematically sur-
veyed, to determine if this is a truly ubiquitous function.
At ¢rst sight, the association between DING proteins and
calci¢cation seems to have no direct parallel in plant biochem-
istry. Formation of calcium oxalate crystals in specialised vac-
uolar compartments is the most common form of mineralisa-
tion in plants. It is known that proteins are found in the
crystals, but they have not yet been characterised [39]. It
seems possible that DING proteins may be involved in this
process, and this is an obvious area for further study. It
should be noted that kidney stones more commonly contain
calcium oxalate, as opposed to calcium phosphate [40].
8. Molecular cloning of DING coding sequences
Despite the frequency of discovery of these proteins, com-
plete gene sequences coding for eukaryotic DING proteins
have not yet been identi¢ed. This is puzzling, given the recent
rapid progress with both the Arabidopsis and human genomes,
and considering the enormous numbers of expressed sequence
tags now known. Several explanations could account for the
lack of a cDNA clone: very low transcript abundance, mRNA
instability or rapid turnover. However, the absence of a
cloned DING genomic sequence is more di⁄cult to explain.
A recent report, of a relatively low degree of overlap between
the genes so far identi¢ed in the two human genome pro-
grammes, suggests that signi¢cant gaps may still exist in our
knowledge of the human genome [41].
In a recent attempt at obtaining a human DING DNA
clone, internal tryptic peptides from the human 40 kDa pro-
tein were used to design oligonucleotide PCR primers, which
led to ampli¢cation of a putative, partial cDNA sequence of
about 860 bp. About 350 nucleotides at the 5P end of this
sequence are highly homologous with the protein domain
present in dishevelled, egl-10 and pleckstrin proteins (the
DEP domain of the dishevelled protein); the remainder, ap-
parently a continuation of the same open reading frame, codes
for a novel sequence [1].
Dishevelled is a ubiquitous gene family involved in develop-
ment and growth regulation. Its protein product acts as an
intermediate and as a branch point in intracellular signalling
pathways between a G-protein-coupled cell-surface receptor, a
member of the frizzled family, and the glycogen synthase ki-
nase 3b or the JNK kinases [42]. The multiplicity of protein
interactions suggests that the dishevelled protein may act as a
‘sca¡old protein’ in bringing together several elements of sig-
nalling pathways. In addition to its DEP domain, it also has
multiple protein domains found ¢rst in postsynaptic density
protein and Dlg tumour suppressor (PDZ domains) and a
pleckstrin domain. The DEP domain of the dishevelled pro-
tein is found in a variety of other proteins. It is a globular
domain, comprising about 80 amino acids, which interacts
with protein kinases, and may have a role in GTP^GDP ex-
change reactions [43]. It is not known if the SSP/DING pro-
tein has PDZ or pleckstrin domains, but the DEP domain
may imply a possible role in signalling reactions through in-
teraction with a protein kinase.
9. Hypothesis : a ubiquitous signalling role for DING proteins
In animals, DING proteins seem to be associated with im-
portant signalling functions, possibly through interactions
with speci¢c ligands in the extracellular space. Up to now,
genistein and cotinine as well as bacterial surface polysaccha-
rides have been identi¢ed as DING ligands. Much less is
known at present about the possible roles of plant DING
proteins, but functional conservation would suggest that
they may also be involved in autocrine or intercellular signal
transmission.
Although little work has as yet been done on ligand binding
by plant DING proteins, it may be signi¢cant that genistein
and cotinine are plant products or derivatives thereof. Plant
DING proteins could themselves function as binding proteins
or transporters of endogenous or extraneous bioactive metab-
olites, analogous to the known auxin-binding proteins [44].
Interaction of these metabolites with the homologous human
or animal DING proteins could explain their diverse pharma-
cological actions. An analogously interacting system has been
proposed by McLachlan and coworkers [45], who have shown
that £avonoids, involved in signalling between legumes and
their rhizobial symbionts, also act as ‘endocrine disrupters’.
Genistein and the related iso£avones, apigenin and chrysin,
are active in this system. Interestingly, some of the plant
GLPs, with which DING proteins seem to associate in vivo,
have been identi¢ed as auxin-binding proteins while others
bind a Rhizobium protein, named rhicadhesin, that is involved
in the ¢rst step of the bacterial root recognition process [46].
Logical extrapolation of this hypothesis suggests that the
genistein^DING interaction, which inhibits breast carcinoma
proliferation, antagonises a similar interaction between DING
and a human cell-derived metabolite with growth-promoting
properties. Similarly, in neurones, the DING protein would
interact with a similar metabolite to modulate neurotransmit-
ter functions, and this interaction would be inhibited or dis-
placed by a cotinine^DING interaction [17]. A simpler variant
of the hypothesis would be that the mammalian DING pro-
teins no longer bind an endogenous metabolite as part of their
signalling function, but retain an ancestral binding site that is
targeted by these plant metabolites.
Some of these signalling pathways are linked to the activa-
tion of cell growth, and appear to contribute to the inappro-
priate proliferation, which is a feature of both cancer and RA
[47]. A better understanding of these pathways may also lead
to the discovery or development of DING-binding ligands
with potentially greater therapeutic value.
Much work will be needed to fully understand the diverse
functions of DING proteins, but at this point it is tempting to
speculate that they represent important partners in novel sig-
nalling pathways common to plants and animals, as well as
play a role in biomineralisation processes.
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